放射治疗和治疗术:兰塞特杂志的瘤学委员会
May Abdel-Wahab1, Francesco Giammarile1, Mauro Carrara1
1Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.
The Lancet. Oncology
|October 3, 2024
概括
全球对放射疗法和疗神疗法的获取仍然不平等. 实施新技术,如低分离和支持倡议,可以扩大治疗的可用性,特别是在低收入和中等收入国家 (LMICs).
科学领域:
- 在瘤学瘤学.
- 辐射疗法 辐射疗法
- 超级神奇主义者 超级神奇
背景情况:
- 在高收入国家和低收入和中等收入国家 (LMICs) 之间,放射治疗机器的可用性存在显著差异.
- 缺乏经过培训和认证的医疗保健专业人员限制了放射治疗的实施,特别是在LMICs.
- 由于供应链,劳动力和监管挑战,除-131外,对放射性药物治疗的获取在全球范围内高度变化.
研究的目的:
- 评估当前全球辐射疗法和治疗术的获取和可用性.
- 确定和调查可以减轻辐射疗法获取差异的举措.
- 建议采取行动和投资,以加强全球对放射治疗和疗神疗法的获取,特别是在LMICs.
主要方法:
- 对现有数据的分析和对辐射疗法和治疗术可用性的全球调查.
- 调查诸如延长治疗时间,低分离方案和新技术等举措.
- 评估影响theranostics访问的劳动力,供应链和监管因素.
主要成果:
- 在前列腺癌和乳腺癌中实施低分化可以使用现有资源为额外的220万患者提供放射治疗.
- 放射性同位素生产能力是theranostics的一个关键问题,与劳动力培训和监管框架一起.
- 全球对放射性药物治疗的准入 (不包括131I) 显示出显著的变化.
结论:
- 新技术和举措,如国际原子能机构的希望之光计划,对于改善全球辐射治疗的准入至关重要.
- 在政府和国际机构的支持下,投资于放射治疗和治疗术是减少癌症负担的关键.
- 公平获得放射治疗和疗神疗法,特别是在LMICs,可以带来显著的健康和经济效益.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.